RocketTickers

Agios Announces FDA Orphan Drug Designation Granted to Mitapivat

Long
NASDAQ:AGIO   Agios Pharmaceuticals, Inc.
AGIO: Agios Pharmaceuticals, Inc.
2020-11-12 16:30:16
Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Sickle Cell Disease
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.